Etokimab (I-Mab Biopharma), which is optimized for common IL-33 gene polymorphisms, has completed patient recruitment in its ...

Peter L. Salgo, MD: How do the biologics impact the asthma inflammatory pathway, and what is the targeted pathway for the treatment of asthma in the first place? Linda S. Cox, MD, FAAAAI, FACAAI, FACP ...

Asthma affects millions worldwide, including around 12% of children aged 6–7. 1 Although symptoms for all asthma patients share a common set of traits (chest tightness, shortness of breath, wheezing, ...

Asthma is a complex airway disorder that involves multiple inflammatory cells and cellular elements. Genetic and environmental factors result in recurrent episodes of the symptoms of asthma: coughing, ...

Jan. 8, 2004 — Asthma can be subtyped into four groups based on age and the presence of eosinophils, according to the results of a cross-sectional analysis published in the January issue of the ...

Please provide your email address to receive an email when new articles are posted on . The effect of electronic cigarettes without nicotine on allergic airway disease may depend on flavor, which ...

Among adolescents with asthma and overweight or obesity, the relative risk for acute asthma exacerbations was significantly reduced with GLP-1 receptor agonist use vs. nonpharmacological weight ...

Commonly prescribed beta 2 adrenergic agonist drugs for the treatment of asthma in pregnant women as well as pre-term labor may increase the incidence of autism-spectrum disorders, psychiatric ...

GSK on Tuesday said two late-stage trials of an asthma drug that could have peak sales of more than £3 billion ($3.8 billion) met their goals. GSK GSK UK:GSK said both trials of depemokimab reduced ...